Comparing measures of adherence and persistence to P2Y12 inhibitors in acute coronary syndromes

No abstract available.

Information

Citation

Moon J, Ozaki AF, Chong A, Sud M, Fang J, Austin PC, Ko DT, Jackevicius CA. Am J Cardiol. 2024; S0002-9149(24)00329-1. Epub 2024 Apr 30.

View Source

Contributing ICES Scientists

Research Programs

Cardiovascular

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

28/04/2025

SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors

Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. JAMA Intern Med. 2025; Apr 28 [Epub ahead of print].

Journal Article

23/04/2025

Real-world comparative effectiveness and safety of pertuzumab in patients with HER2+ metastatic breast cancer: a pan-Canadian population-based cohort study

Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O’Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW; CanREValue Collaboration. Int J Cancer. 2025; Apr 23 [Epub ahead of print].

Journal Article

23/04/2025

Variations of the extent of obstructive coronary artery disease among Canadian immigrants

Nouraei H, Qiu F, Haldenby O, Abdel-Qadir H, Deb S, Madan M, Shah BR, Sud M, Vyas MV, Wijeysundera HC, Ko DT. J Am Heart Assoc. 2025; e037534. Epub 2025 Apr 23.

See All